Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Expression analysis of LacZ gene placed in the locus of Cnot7 exhibits its activity in osteoblasts in vivo and in mineralized nodules in vitro.

Washio-Oikawa K, Nakamura T, Usui M, Yoneda M, Ezura Y, Ishikawa I, Nakashima K, Yamamoto T, Noda M.

J Cell Biochem. 2006 Oct 1;99(2):538-44.

PMID:
16639713
2.

Cnot7-null mice exhibit high bone mass phenotype and modulation of BMP actions.

Washio-Oikawa K, Nakamura T, Usui M, Yoneda M, Ezura Y, Ishikawa I, Nakashima K, Noda T, Yamamoto T, Noda M.

J Bone Miner Res. 2007 Aug;22(8):1217-23.

3.

The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells.

Boban I, Jacquin C, Prior K, Barisic-Dujmovic T, Maye P, Clark SH, Aguila HL.

Bone. 2006 Dec;39(6):1302-12. Epub 2006 Aug 30.

PMID:
16938497
4.

Daily low-intensity pulsed ultrasound-mediated osteogenic differentiation in rat osteoblasts.

Suzuki A, Takayama T, Suzuki N, Sato M, Fukuda T, Ito K.

Acta Biochim Biophys Sin (Shanghai). 2009 Feb;41(2):108-15.

5.

Constitutive expression of thrombospondin 1 in MC3T3-E1 osteoblastic cells inhibits mineralization.

Ueno A, Miwa Y, Miyoshi K, Horiguchi T, Inoue H, Ruspita I, Abe K, Yamashita K, Hayashi E, Noma T.

J Cell Physiol. 2006 Nov;209(2):322-32.

PMID:
16883596
6.

Oligo-astheno-teratozoospermia in mice lacking Cnot7, a regulator of retinoid X receptor beta.

Nakamura T, Yao R, Ogawa T, Suzuki T, Ito C, Tsunekawa N, Inoue K, Ajima R, Miyasaka T, Yoshida Y, Ogura A, Toshimori K, Noce T, Yamamoto T, Noda T.

Nat Genet. 2004 May;36(5):528-33. Epub 2004 Apr 25.

PMID:
15107851
7.

Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes.

Hirao M, Hashimoto J, Yamasaki N, Ando W, Tsuboi H, Myoui A, Yoshikawa H.

J Bone Miner Metab. 2007;25(5):266-76. Epub 2007 Aug 25.

PMID:
17704991
8.

Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.

Gazzerro E, Deregowski V, Stadmeyer L, Gale NW, Economides AN, Canalis E.

Bone. 2006 Dec;39(6):1252-60. Epub 2006 Aug 24.

PMID:
16934545
9.

Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo.

Selvamurugan N, Jefcoat SC, Kwok S, Kowalewski R, Tamasi JA, Partridge NC.

J Cell Biochem. 2006 Oct 1;99(2):545-57.

PMID:
16639721
10.

Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.

Nakamura A, Ly C, Cipetić M, Sims NA, Vieusseux J, Kartsogiannis V, Bouralexis S, Saleh H, Zhou H, Price JT, Martin TJ, Ng KW, Gillespie MT, Quinn JM.

Bone. 2007 Feb;40(2):305-15. Epub 2006 Oct 13.

PMID:
17049328
11.
12.

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.

Qiang YW, Chen Y, Stephens O, Brown N, Chen B, Epstein J, Barlogie B, Shaughnessy JD Jr.

Blood. 2008 Jul 1;112(1):196-207. doi: 10.1182/blood-2008-01-132134. Epub 2008 Feb 27.

13.

Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass conditioned medium in the absence of osteogenic supplements.

Tsigkou O, Jones JR, Polak JM, Stevens MM.

Biomaterials. 2009 Jul;30(21):3542-50. doi: 10.1016/j.biomaterials.2009.03.019. Epub 2009 Mar 31.

PMID:
19339047
14.

Effects of core binding factor alpha1 or bone morphogenic protein-2 overexpression on osteoblast/cementoblast-related gene expressions in NIH3T3 mouse cells and dental follicle cells.

Pan K, Yan S, Ge S, Li S, Zhao Y, Yang P.

Cell Prolif. 2009 Jun;42(3):364-72. doi: 10.1111/j.1365-2184.2009.00599.x. Epub 2009 Apr 24.

PMID:
19397592
15.

Taurine transporter is expressed in osteoblasts.

Yuan LQ, Xie H, Luo XH, Wu XP, Zhou HD, Lu Y, Liao EY.

Amino Acids. 2006 Sep;31(2):157-63. Epub 2006 May 26.

PMID:
16729199
16.

Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro.

Ideno H, Takanabe R, Shimada A, Imaizumi K, Araki R, Abe M, Nifuji A.

Exp Cell Res. 2009 Feb 1;315(3):474-84. doi: 10.1016/j.yexcr.2008.11.019. Epub 2008 Dec 6.

PMID:
19073177
17.

Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption.

Yeo H, Beck LH, Thompson SR, Farach-Carson MC, McDonald JM, Clemens TL, Zayzafoon M.

J Biol Chem. 2007 Nov 30;282(48):35318-27. Epub 2007 Sep 19.

18.

Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.

Irie A, Takami M, Kubo H, Sekino-Suzuki N, Kasahara K, Sanai Y.

Bone. 2007 Aug;41(2):165-74. Epub 2007 May 5.

PMID:
17560185
19.

The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation.

Aslam A, Mittal S, Koch F, Andrau JC, Winkler GS.

Mol Biol Cell. 2009 Sep;20(17):3840-50. doi: 10.1091/mbc.E09-02-0146. Epub 2009 Jul 15.

20.

Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism.

Thommesen L, Stunes AK, Monjo M, Grøsvik K, Tamburstuen MV, Kjøbli E, Lyngstadaas SP, Reseland JE, Syversen U.

J Cell Biochem. 2006 Oct 15;99(3):824-34.

PMID:
16721825
Items per page

Supplemental Content

Write to the Help Desk